| WHITEPAPERS |
Use Adherence Packaging to Maximize Adherence
By leveraging co-pay support programs as front-end patient acquisition tactics, marketers can use them as a means of engaging patients in the brand’s integrated and multifaceted marketing stream.
Sponsor: TrialCard
|
Use Adherence Packaging to Maximize Adherence
Medication adherence is a broadly recognized problem that compromises both clinical and economic outcomes of drug treatments. Medication adherence is also a problem with a solution. The use of what is often called “smart packing,” standard pharmaceutical packages with an embedded microchip to detect opening and closing, can give healthcare providers key information on precisely when each dose was taken—or when it was missed. The ability to identify and quantify both adherence and nonadherence promises to improve clinical outcomes and reduce overall healthcare spending.
Sponsor: WestRock
|
|
2016 Chevrolet Malibu: Mobile Technology for Pharmaceutical Re
The all-new 2016 Chevrolet Malibu offers exceptional style, safety, and efficiency that will be popular with reps and desirable for fleet managers. Read this whitepaper and infographic that demonstrate the features and technologies that make Chevrolet Malibu a great option for pharma fleets.
Sponsor: General Motors Fleet
|
Speed to Insight: Four strategies you need to maximize the value of your data assets
Sponsor: Hewlett Packard Enterprise
How can you get your drug to market faster? Join Hewlett Packard Enterprise and Linguamatics as they discuss accelerating your company’s data analytics capabilities. This Executive Summary will provide case studies that illustrate how you can use analytics across the drug development pipeline to support better-informed business decisions and gain competitive advantage.
|
Transparency of HCP Interactions is a Global Movement!
Sponsor: AHM
With the deadline for EFPIA reporting quickly approaching (on or before June 30, 2016) life sciences organizations leaning on best practices and learnings they have gleaned from the Open Payments Program a.k.a. Sunshine Act. As the relationships between industry and healthcare professionals are often in question, financial disclosure programs showcasing ‘transfers of value’ or forms of remuneration to the HCP is growing to further enable trust between patients, physicians and life sciences. This white paper explores the similarities of what data needs to be captured and available for reporting as well as highlights the differences and challenges of implementing a non-mandated program.
|
|
The Goldilocks Hub
Sponsor: Triplefin
|
|
Safety, regulatory, BRM for established products
This paper examines the changing environment for marketed, or established, products. Authors discuss emerging markets, recent divestment discussions, challenges in the current model -- and a proposed solution for how biopharmaceutical companies can more effectively manage the routine maintenance required to maximize the value of these product portfolios.
Sponsor: Quintiles
|
|
Micromarketing to Physicians in the Changing Medical Landscape
Marketing to physicians is evolving at light speed—are you taking advantage of the latest technologies and platforms to target physicians? MDalert.com’s new white paper provides an overview of the dynamic landscape in micro-targeting physicians, as well as evidence that our new mobile-optimized digital platform drives physician engagement in this era of performance-driven healthcare.
Sponsor: MDalert.com
|
|
Co-Pay Analytics Gets Serious
How do you really know if your co-pay program is working? Figuring ROI seems straightforward. But Paul LeVine, Vice President of Analytic Services for TrialCard Market Access Solutions thinks the calculus might require a deeper look than is traditionally given as he explained at the 2nd Annual Coupon and Co-Pay Strategy Summit in Philadelphia in February.
Sponsor: TrialCard Inc.
|
|
Hub Change
Transitioning Hub programs in daunting. But making a major change can be a necessary step to foster a brand’s performance through improved patient support services. At CBI’s 6th Annual Hub and SPP Model Optimization Conference in Philadelphia this February, Scott Dulitz of Trialcard outlines key points of consideration and best practices to fast track the switch to move forward once you’ve come to the conclusion that a change is necessary.
Sponsor: TrialCard Inc.
|
|
Data Quality Keeping You Awake?
The Life Sciences industry is enduring close regulatory scrutiny, which is likely to continue to expand in scope. For Life Sciences, compliance regulations and practices such as the Physicians Payment Sunshine Act require extensive documentation related to financial and policies management as well as the data associated with these processes. There is not a one size fits all approach resulting in fragmented processes, and copious systems whose remit is to define and collect valuable data. Discover lessons learned and review solutions to ensuring valuable data collection and quality reporting.
Sponsor: AHM
|
